Examine impressive results for simple, uncomplicated clot prevention
See extensive results for the most studied anticoagulant of its kind
View the direct inhibition of Factor Xa, an active area of research
Thromboembolic disorders pose life threatening risks to millions of patients
Connect with a world of events devoted to thromboembolic research
Learn more about ‘Xarelto’ and Thrombosis by watching videos and using interactive tools
The RECORD Programme
Desirable Characteristics of an Anticoagulant
History of Warfarin
Pooled Analysis of RECORD1, 2, and 3
Results of the Landmark RECORD Programme
Xarelto Countdown
Mode of Action of ‘Xarelto’
Potential Health Economics Benefits of 'Xarelto'
Challenging the Burden of Mortality in ACS
Widening the Gap Between Risk and Benefit
Venous Thrombus Formation and Break Away